Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Compare 401(k) options by evaluating index funds against target date funds to see which aligns with your retirement plan and risk tolerance.
25,660 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Friday brought a sharp move in Kindercare Learning Companies stock as soft guidance overshadowed a quarterly beat. Th...
Grab is moving to pilot a new delivery robot in Singapore’s Punggol district by late 2026, aiming to relieve labor sh...
Newmont faced a sharp one-day decline as gold trends shifted and market risks crept in. This article breaks down the ...
Palantir has surprised and divided investors with big moves and bold AI promises. This guide explains what to watch, ...
Investors are weighing whether to buy Chewy stock before March 25. This guide breaks down the earnings setup, busines...
A Navy veteran spearheads a Harvard-style real estate network aimed at elevating service members’ homebuying experien...
Investing in AI stocks can feel like a fast-moving target. This article breaks down whether penguin solutions next st...
Pediatrix Medical Group stock tumbled on Thursday after earnings highlighted modest revenue pressures and GAAP vs non...
Centene's Sarah London, the youngest-ever female Fortune 500 CEO, is steering a bold reinvention of the nation's larg...
As Walmart gears up for 2027, investors need a clear view of how groceries, online sales, and international markets s...
No annual fee doesn’t mean low value. This guide highlights the best 2023 cash back rewards cards with no fees, plus ...